Literature DB >> 24857828

Prenatal alcohol exposure causes the over-expression of DHAND and EHAND by increasing histone H3K14 acetylation in C57 BL/6 mice.

Weihua Zhang1, Chang Peng1, Min Zheng1, Wenqun Gao1, Jing Zhu2, Tiewei Lv1, Lingjuan Liu2, Zhenguo Liu3, Huan Li1, Yang Xv1, Jie Tian4.   

Abstract

Prenatal alcohol exposure leads to congenital heart abnormal development, its mechanisms are still unknown. Recent reports have associated alcohol exposure with histone H3 acetylation. In the present study, we have performed the experiments to test the hypothesis that histone H3K14 acetylation is the key role in the fetal heart leads to over-expression of cardiac specific genes DHAND and EHAND caused by prenatal alcohol exposure. Seventy pregnant C57BL/6 mice were divided randomly into seven groups (n=10). They were the untreated group, dimethyl sulfoxide group, alcohol exposure group, curcumin treatment group, both alcohol and curcumin treatment group, SAHA treatment group, both alcohol and SAHA treatment group. Fetal mouse hearts were collected on embryonic day 14.5. The changes of HATs activities, the acetylation levels of histone H3K14 (H3K14ac), the expression levels of cardiac specific genes DHAND and EHAND, and structure of chromatin were determined. Our data indicates that curcumin and SAHA significantly reduces and increases the activities of HATs and the levels of histone H3K14ac in fetal hearts, respectively. The expression of DHAND and EHAND is significantly down-regulated and up-regulated in the groups treated with curcumin and SAHA. Furthermore, our results from ChIP assays have shown that the histone H3K14ac connects with the DHAND and EHAND genes are significantly inhibited by curcumin and simulated by SAHA. Our study suggests that prenatal alcohol exposure causes the over-expression of DHAND and EHAND by increasing H3K14ac in mice.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Curcumin; DHAND; EHAND; Histone H3K14 acetylation; Prenatal alcohol exposure; SAHA

Mesh:

Substances:

Year:  2014        PMID: 24857828     DOI: 10.1016/j.toxlet.2014.05.011

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  8 in total

Review 1.  Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning.

Authors:  K E Boschen; S M Keller; T L Roth; A Y Klintsova
Journal:  Neurotoxicol Teratol       Date:  2018-01-02       Impact factor: 3.763

2.  Signaling Pathways in Pregnancy.

Authors:  Giovanni Tossetta; Daniela Marzioni
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

3.  Inhibition of histone acetylation by curcumin reduces alcohol-induced fetal cardiac apoptosis.

Authors:  Xiaochen Yan; Bo Pan; Tiewei Lv; Lingjuan Liu; Jing Zhu; Wen Shen; Xupei Huang; Jie Tian
Journal:  J Biomed Sci       Date:  2017-01-05       Impact factor: 8.410

Review 4.  Epigenetics studies of fetal alcohol spectrum disorder: where are we now?

Authors:  Alexandre A Lussier; Joanne Weinberg; Michael S Kobor
Journal:  Epigenomics       Date:  2017-02-17       Impact factor: 4.778

Review 5.  The Multifaced Actions of Curcumin in Pregnancy Outcome.

Authors:  Giovanni Tossetta; Sonia Fantone; Stefano Raffaele Giannubilo; Daniela Marzioni
Journal:  Antioxidants (Basel)       Date:  2021-01-17

Review 6.  Epigenetic Mechanisms in Developmental Alcohol-Induced Neurobehavioral Deficits.

Authors:  Balapal S Basavarajappa; Shivakumar Subbanna
Journal:  Brain Sci       Date:  2016-04-08

Review 7.  In Utero Alcohol Exposure and the Alteration of Histone Marks in the Developing Fetus: An Epigenetic Phenomenon of Maternal Drinking.

Authors:  Chanchal Mandal; Debasish Halder; Kyoung Hwa Jung; Young Gyu Chai
Journal:  Int J Biol Sci       Date:  2017-09-05       Impact factor: 6.580

Review 8.  The Effects of Early Prenatal Alcohol Exposure on Epigenome and Embryonic Development.

Authors:  Essi Wallén; Pauliina Auvinen; Nina Kaminen-Ahola
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.